|
FAM72D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68398628375144E-12 |
| Normal-vs-Stage2 |
4.23360000390005E-08 |
| Normal-vs-Stage3 |
3.53699999955381E-07 |
| Normal-vs-Stage4 |
2.20989999999421E-06 |
| Stage1-vs-Stage2 |
7.638400E-01 |
| Stage1-vs-Stage3 |
8.508200E-02 |
| Stage1-vs-Stage4 |
5.997800E-03 |
| Stage2-vs-Stage3 |
1.630440E-01 |
| Stage2-vs-Stage4 |
1.046440E-02 |
| Stage3-vs-Stage4 |
1.174230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.39319999770527E-08 |
| Normal-vs-Asian |
2.464400E-02 |
| Caucasian-vs-AfricanAmerican |
9.576700E-03 |
| Caucasian-vs-Asian |
9.429600E-01 |
| AfricanAmerican-vs-Asian |
1.830030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64568358940187E-12 |
| Normal-vs-Female |
1.52100554373646E-14 |
| Male-vs-Female |
6.671500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.123900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.3483003602488E-10 |
| Normal-vs-Age(61-80Yrs) |
1.69875224997895E-12 |
| Normal-vs-Age(81-100Yrs) |
2.369100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.351610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.998790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.220100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.845800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.080400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.652020E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.02380000000102E-05 |
| Normal-vs-Grade 2 |
1.62825308791525E-12 |
| Normal-vs-Grade 3 |
7.29590055037477E-10 |
| Normal-vs-Grade 4 |
4.41839999998361E-06 |
| Grade 1-vs-Grade 2 |
5.632200E-01 |
| Grade 1-vs-Grade 3 |
3.762200E-01 |
| Grade 1-vs-Grade 4 |
6.181600E-03 |
| Grade 2-vs-Grade 3 |
5.831000E-01 |
| Grade 2-vs-Grade 4 |
8.356800E-03 |
| Grade 3-vs-Grade 4 |
1.695960E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.71418435002124E-12 |
| Normal-vs-ccB subtype |
3.46319994903865E-09 |
| ccA subtype-vs-ccB subtype |
1.625650E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.53770354624794E-11 |
| Normal-vs-N1 |
2.981500E-03 |
| N0-vs-N1 |
3.397800E-02 |
|
|
